| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |